Diabetes prevention - From physiology to implementation

被引:28
作者
Schwarz, P. E. H. [1 ]
Schwarz, J. [1 ]
Bornstein, S. R. [1 ]
Schulze, J. [1 ]
机构
[1] Tech Univ Dresden, Med Fac Carl Gustav Carus, Med Clin 3, Dept Endocrinopathies & Metab Dis, D-01307 Dresden, Germany
关键词
prevention; type; 2; diabetes; insulin resistance; TUMAINI;
D O I
10.1055/s-2006-947839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One of the major challenges today is the development of prevention programs for the clinical practice. Our aim was to develop a concept for a primary diabetes prevention program to be implemented in general health care. Lifestyle intervention addressing diet and exercise has reduced the diabetes risk by up to 58 %. Early preventive pharmacological strategies have yielded a diabetes risk reduction,of 25-30 %. These findings offer a compelling evidence base, but delivery of intervention and care is essential. The challenge therefore is the management of prevention and intervention programs considering scientific aspects and practical requirements during implementation. The Diabetes Prevention Workgroup at the German Diabetes Association has developed a concept for a decentralized prevention program. Based on the results of the prevention studies, the intervention concept consists of a three-step program including identification of the individuals at high risk to develop type 2 diabetes (I), followed by general intervention based on individual choice (2) and maintained continuous intervention for motivation maintenance (3). Structured prevention programs will enable nationwide prevention of diabetes mellitus without consuming large resources. This process will be challenging and time consuming, requiring many partners but resulting in a profitable "health" investment.
引用
收藏
页码:460 / 464
页数:5
相关论文
共 21 条
[1]   TRIPOD (TRoglitazone in the Prevention of Diabetes): A randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus [J].
Azen, SP ;
Peters, RK ;
Berkowitz, K ;
Kjos, S ;
Xiang, A ;
Buchanan, TA .
CONTROLLED CLINICAL TRIALS, 1998, 19 (02) :217-231
[2]   The STOP-NIDDM Trial -: An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance:: rationale, design, and preliminary screening data [J].
Chiasson, JL ;
Gomis, R ;
Hanefeld, M ;
Josse, RG ;
Karasik, A ;
Laakso, M .
DIABETES CARE, 1998, 21 (10) :1720-1725
[3]   Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
LANCET, 2002, 359 (9323) :2072-2077
[4]  
Haffner SM, 2002, INT J CLIN PRACT, P33
[5]   Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234
[6]  
Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
[7]  
Liebl A, 2000, MMW Fortschr Med, V142, P39
[8]   Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance - The Da Qing IGT and diabetes study [J].
Pan, XR ;
Li, GW ;
Hu, YH ;
Wang, JX ;
Yang, WY ;
An, ZX ;
Hu, ZX ;
Lin, J ;
Xiao, JZ ;
Cao, HB ;
Liu, PA ;
Jiang, XG ;
Jiang, YY ;
Wang, JP ;
Zheng, H ;
Zhang, H ;
Bennett, PH ;
Howard, BV .
DIABETES CARE, 1997, 20 (04) :537-544
[9]   The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) [J].
Ramachandran, A ;
Snehalatha, C ;
Mary, S ;
Mukesh, B ;
Bhaskar, AD ;
Vijay, V .
DIABETOLOGIA, 2006, 49 (02) :289-297
[10]   Primary prevention of type 2 diabetes through nutritional counseling [J].
Sartorelli, DS ;
Sciarra, EC ;
Franco, LJ ;
Cardoso, MA .
DIABETES CARE, 2004, 27 (12) :3019-3019